Genetic test maker Affymetrix Inc. has agreed to buy back $95.5 million of notes bought by the investment firm Tang Capital Partners and others to settle a lawsuit filed in Santa Clara Superior Court.
Tang sued Santa Clara-based Affymetrix for fraud in December, claiming the company had used money set aside to repurchase the notes as collateral to finance its $330 million acquisition of eBioscience Holding Co., announced on Nov. 30.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
